/
/
/

Medicamen Biotech Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)307.95
Volume (₹)36,614.00
High (₹)319.80
Upper Circuit321.80
Low (₹)292.40
Lower Circuit291.20
Prev Close306.50
52W High (₹)447.65
Price315.00
52W Low (₹)212.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)418.95 Cr
Div. Yield (%)0.32
PE Ratio38.69
Debt to Equity0.16
Price to Book2.97
Book Value162.23
EPS (TTM)7.98
Face Value10.00
ROE (%)3.23

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
MEDICAMEQ-BENSE
LTP
1W Low
1W High
Market cap (₹)
1852.2+14.9 (0.81%)
1832.20
1891.50
4,44,597Cr
9619.5+244.5 (2.61%)
9312.50
9740
2,55,195Cr
4988.5+148.5 (3.07%)
4848.50
5010
1,87,712Cr
1203.9+43.9 (3.78%)
1152.10
1208.60
1,17,705Cr
1399.7+5.2 (0.37%)
1364.50
1421
1,13,423Cr
2007+53 (2.71%)
1963.80
2055.30
1,09,481Cr
2474.9+174.2 (7.57%)
2303
2504.60
1,02,229Cr
1201+16 (1.35%)
1185
1222
1,00,195Cr
1712-22 (-1.27%)
1689.30
1740
98,965Cr
2092+9 (0.43%)
2077.50
2135
95,939Cr
315-13.05 (-3.98%)
292.40
339.70
419Cr

Key Highlights of Medicamen Biotech Ltd Balance Sheet

Medicamen Biotech Ltd balance sheet discloses shareholders' funds of ₹12.71Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹12.71Cr, and the reserves and surplus of the company is ₹204.92Cr.

The company has its non-current liabilities with total liabilities of ₹290.38Cr as of 2025-03-31.

The current liabilities are ₹72.58Cr as of 2025-03-31. At the same time, current assets are ₹153.51Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹8.06Cr and tangible assets of ₹86.31Cr, provided in the Medicamen Biotech Ltd financial statements.